Stocks News

LAST PRICE
47.2500
TODAY'S CHANGE (%)
Trending Up0.4000 (0.8538%)

Bid / Lots
47.2500/ 26
Ask / Lots
47.8800/ 1
Open / Previous Close
47.6100 / 46.8500
Day Range
Low 46.3000
High 48.4400
52 Week Range
Low 43.4200
High 91.1000
Volume
3,133,146
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 14, 2024
- CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: CRSP
  
  CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
  
  ZUG, Switzerland and BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of CRISPR Therapeutics, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at 4:00 p.m. GMT.
Nov 7, 2024
- CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: CRSP
  
  CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
  
  ZUG, Switzerland and BOSTON, Nov. 07, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of CRISPR Therapeutics, will present at the Guggenheim Inaugural Healthcare Innovation Conference on Tuesday, November 12, 2024, at 2:00 p.m. ET.
Nov 6, 2024
- DJ Crispr Therapeutics Price Target Maintained With a $53.00/Share by RBC Capital, from 11:28AM ET on Wednesday Nov 06, 2024 by Dow Jones
  11:28AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CRSP
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRSP/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 11:28 ET (16:28 GMT)
- DJ Crispr Therapeutics Is Maintained at Equal-Weight by Barclays, from 9:29AM ET on Wednesday Nov 06, 2024 by Dow Jones
  9:29AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CRSP
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRSP/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 09:29 ET (14:29 GMT)
- DJ Crispr Therapeutics Price Target Maintained With a $84.00/Share by Needham, from 5:41AM ET on Wednesday Nov 06, 2024 by Dow Jones
  5:41AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: CRSP
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/CRSP/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 05:41 ET (10:41 GMT)

Nov 13, 2024
- Denali Therapeutics Insider Sold Shares Worth $1,932,665, According to a Recent SEC Filing, from 7:06PM ET on Wednesday Nov 13, 2024 by MT Newswires
  7:06PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: DNLI
- RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
Nov 12, 2024
- Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: HON, RGEN, AXSM
- DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 11:20AM ET on Tuesday Nov 12, 2024 by Dow Jones
  11:20AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: RARE
- Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: IBB, RGEN, XLV, AZN, AXSM
- Axsome Therapeutics Q3 Loss Widens, Revenue Increases, from 7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires
  7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: AXSM
- DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones
  7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: AXSM
- -- Earnings Flash (AXSM) AXSOME THERAPEUTICS Reports Q3 Revenue $104.8M, from 7:11AM ET on Tuesday Nov 12, 2024 by MT Newswires
  7:11AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: AXSM

CRISPR Therapeutics AG
NASDAQ:CRSPUnited States

Search Criteria

Nov 14, 2024

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 7, 2024

CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

DJ Crispr Therapeutics Price Target Maintained With a $53.00/Share by RBC Capital, from 11:28AM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Crispr Therapeutics Is Maintained at Equal-Weight by Barclays, from 9:29AM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Crispr Therapeutics Price Target Maintained With a $84.00/Share by Needham, from 5:41AM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Nov 13, 2024

Denali Therapeutics Insider Sold Shares Worth $1,932,665, According to a Recent SEC Filing, from 7:06PM ET on Wednesday Nov 13, 2024 by MT Newswires

RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires

DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires

DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 11:20AM ET on Tuesday Nov 12, 2024 by Dow Jones

Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires

Axsome Therapeutics Q3 Loss Widens, Revenue Increases, from 7:52AM ET on Tuesday Nov 12, 2024 by MT Newswires

DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 7:50AM ET on Tuesday Nov 12, 2024 by Dow Jones

-- Earnings Flash (AXSM) AXSOME THERAPEUTICS Reports Q3 Revenue $104.8M, from 7:11AM ET on Tuesday Nov 12, 2024 by MT Newswires